Transparent Thinking Blog

TrialAssure cubes divider
clinical trial disclosure transparency pharma biotech medical device fda ema health canada prci data anonymization document redaction services solutions technology expert patient engagement plain language summary lay summary

Groundbreaking Transparency Application that Anonymizes Patient Data in Clinical Trials Launched by TrialAssure

Read More
Cuban Public Registry of Clinical Trials services help solutions regulation compliance trialassure technology solutions expert

REGISTRY SNAPSHOT: Cuban Public Registry of Clinical Trials

Read More

This week in transparency news: February 16 – February 22, 2019

Read More fda clinical trial registry disclosure transparency services solutions trialassure technology clinical trials


Read More
Should people share their DNA for drug development purposes? – USA Today Many people don’t realize that sharing a DNA sample with, 23andMe and others can result in their data being shared. However, this week, the companies pledged that they would disclose when data is shared with corporations or the government. With a $300 million investment by GSK in 23andMe, they state that approximately 80 percent of customers have agreed to share their DNA data. This data is being de-identified before it is shared.

This week in transparency news: February 9 – February 15, 2019

Read More
Clinical Trials Registry India (CTRI) trialassure

REGISTRY SNAPSHOT: Clinical Trials Registry India (CTRI)

Read More
The U.S. Senate had voted in favor of an opioid bill that expands Open Payments to include payments made to Nurse Practitioners, Physician Assistants, Nurse Midwifes, Nurse Anesthetists, and Clinical Nurse Specialists, in addition to current physician reporting requirements. This will go into effect beginning January 1, 2022. Inconsistent Clinical Trial Disclosure and Lack of Compliance Across Big Pharma

This week in transparency news: February 2 – February 8, 2019

Read More
Clinical Trial Register of Singapore

REGISTRY SNAPSHOT: Clinical Trial Register of Singapore

Read More

This week in transparency news: January 26 – February 1, 2019

Read More
TrialAssure In support of an ongoing effort to increase transparency, Health Canada intends to implement five proposals related to prescription drugs and biologics by October 1, 2018. The proposals come from a division within Health Canada—the Health Products and Food Branch (HPFB)—as part of two 2015 transparency initiatives for drugs, biologics and medical devices.

TrialAssure Creates Higher Education Discount Pricing Model for Clinical Trial Disclosure Reporting Software

Read More
Get in Touch

Looking to streamline your clinical trial disclosure and transparency efforts?

TrialAssure is ready to help your organization embark on a Transparency Transformation!

To learn more about the TrialAssure Transparency Suite, specific products, or our company, contact us below.

Yes, please send me more information about TrialAssure.